RNPC3 and cancer: Among the rarer autoantibodies, anti-U3-RNP/fibrillarin (138) and anti-RNPC-3, usually associated with limited cutaneous disease but severe organ involvement, have been correlated with cancer-associated scleroderma, along with a worse prognosis, comparable to that observed with anti-POLR3 (143).